List of Tables
Table 1. Amyotrophic Lateral Sclerosis Key Market Segments
Table 2. Key Players Covered: Ranking by Amyotrophic Lateral Sclerosis Revenue
Table 3. Ranking of Global Top Amyotrophic Lateral Sclerosis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Amyotrophic Lateral Sclerosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Stem Cell Therapy
Table 6. Key Players of Chemotherapy
Table 7. Global Amyotrophic Lateral Sclerosis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Amyotrophic Lateral Sclerosis Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Amyotrophic Lateral Sclerosis Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Amyotrophic Lateral Sclerosis Market Share by Regions (2015-2020)
Table 11. Global Amyotrophic Lateral Sclerosis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Amyotrophic Lateral Sclerosis Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Amyotrophic Lateral Sclerosis Market Growth Strategy
Table 17. Main Points Interviewed from Key Amyotrophic Lateral Sclerosis Players
Table 18. Global Amyotrophic Lateral Sclerosis Revenue by Players (2015-2020) (Million US$)
Table 19. Global Amyotrophic Lateral Sclerosis Market Share by Players (2015-2020)
Table 20. Global Top Amyotrophic Lateral Sclerosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis as of 2019)
Table 21. Global Amyotrophic Lateral Sclerosis by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Amyotrophic Lateral Sclerosis Product Solution and Service
Table 24. Date of Enter into Amyotrophic Lateral Sclerosis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Amyotrophic Lateral Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 27. Global Amyotrophic Lateral Sclerosis Market Size Share by Type (2015-2020)
Table 28. Global Amyotrophic Lateral Sclerosis Revenue Market Share by Type (2021-2026)
Table 29. Global Amyotrophic Lateral Sclerosis Market Size Share by Application (2015-2020)
Table 30. Global Amyotrophic Lateral Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 31. Global Amyotrophic Lateral Sclerosis Market Size Share by Application (2021-2026)
Table 32. North America Key Players Amyotrophic Lateral Sclerosis Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Amyotrophic Lateral Sclerosis Market Share (2019-2020)
Table 34. North America Amyotrophic Lateral Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 35. North America Amyotrophic Lateral Sclerosis Market Share by Type (2015-2020)
Table 36. North America Amyotrophic Lateral Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 37. North America Amyotrophic Lateral Sclerosis Market Share by Application (2015-2020)
Table 38. Europe Key Players Amyotrophic Lateral Sclerosis Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Amyotrophic Lateral Sclerosis Market Share (2019-2020)
Table 40. Europe Amyotrophic Lateral Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Amyotrophic Lateral Sclerosis Market Share by Type (2015-2020)
Table 42. Europe Amyotrophic Lateral Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Amyotrophic Lateral Sclerosis Market Share by Application (2015-2020)
Table 44. China Key Players Amyotrophic Lateral Sclerosis Revenue (2019-2020) (Million US$)
Table 45. China Key Players Amyotrophic Lateral Sclerosis Market Share (2019-2020)
Table 46. China Amyotrophic Lateral Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 47. China Amyotrophic Lateral Sclerosis Market Share by Type (2015-2020)
Table 48. China Amyotrophic Lateral Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 49. China Amyotrophic Lateral Sclerosis Market Share by Application (2015-2020)
Table 50. Japan Key Players Amyotrophic Lateral Sclerosis Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Amyotrophic Lateral Sclerosis Market Share (2019-2020)
Table 52. Japan Amyotrophic Lateral Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Amyotrophic Lateral Sclerosis Market Share by Type (2015-2020)
Table 54. Japan Amyotrophic Lateral Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Amyotrophic Lateral Sclerosis Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Amyotrophic Lateral Sclerosis Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Amyotrophic Lateral Sclerosis Market Share (2019-2020)
Table 58. Southeast Asia Amyotrophic Lateral Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Amyotrophic Lateral Sclerosis Market Share by Type (2015-2020)
Table 60. Southeast Asia Amyotrophic Lateral Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Amyotrophic Lateral Sclerosis Market Share by Application (2015-2020)
Table 62. India Key Players Amyotrophic Lateral Sclerosis Revenue (2019-2020) (Million US$)
Table 63. India Key Players Amyotrophic Lateral Sclerosis Market Share (2019-2020)
Table 64. India Amyotrophic Lateral Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 65. India Amyotrophic Lateral Sclerosis Market Share by Type (2015-2020)
Table 66. India Amyotrophic Lateral Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 67. India Amyotrophic Lateral Sclerosis Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Amyotrophic Lateral Sclerosis Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Amyotrophic Lateral Sclerosis Market Share (2019-2020)
Table 70. Central & South America Amyotrophic Lateral Sclerosis Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Amyotrophic Lateral Sclerosis Market Share by Type (2015-2020)
Table 72. Central & South America Amyotrophic Lateral Sclerosis Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Amyotrophic Lateral Sclerosis Market Share by Application (2015-2020)
Table 74. GNT Pharma Company Details
Table 75. GNT Pharma Business Overview
Table 76. GNT Pharma Product
Table 77. GNT Pharma Revenue in Amyotrophic Lateral Sclerosis Business (2015-2020) (Million US$)
Table 78. GNT Pharma Recent Development
Table 79. Synthetic Biologics Company Details
Table 80. Synthetic Biologics Business Overview
Table 81. Synthetic Biologics Product
Table 82. Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis Business (2015-2020) (Million US$)
Table 83. Synthetic Biologics Recent Development
Table 84. Avicena Company Details
Table 85. Avicena Business Overview
Table 86. Avicena Product
Table 87. Avicena Revenue in Amyotrophic Lateral Sclerosis Business (2015-2020) (Million US$)
Table 88. Avicena Recent Development
Table 89. Amkor Pharma Company Details
Table 90. Amkor Pharma Business Overview
Table 91. Amkor Pharma Product
Table 92. Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis Business (2015-2020) (Million US$)
Table 93. Amkor Pharma Recent Development
Table 94. Mitsubishi Tanabe Pharma Company Details
Table 95. Mitsubishi Tanabe Pharma Business Overview
Table 96. Mitsubishi Tanabe Pharma Product
Table 97. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Business (2015-2020) (Million US$)
Table 98. Mitsubishi Tanabe Pharma Recent Development
Table 99. Sanofi Company Details
Table 100. Sanofi Business Overview
Table 101. Sanofi Product
Table 102. Sanofi Revenue in Amyotrophic Lateral Sclerosis Business (2015-2020) (Million US$)
Table 103. Sanofi Recent Development
Table 104. Biogen Company Details
Table 105. Biogen Business Overview
Table 106. Biogen Product
Table 107. Biogen Revenue in Amyotrophic Lateral Sclerosis Business (2015-2020) (Million US$)
Table 108. Biogen Recent Development
Table 109. Apotex Business Overview
Table 110. Apotex Product
Table 111. Apotex Company Details
Table 112. Apotex Revenue in Amyotrophic Lateral Sclerosis Business (2015-2020) (Million US$)
Table 113. Apotex Recent Development
Table 114. Mylan Pharmaceuticals Company Details
Table 115. Mylan Pharmaceuticals Business Overview
Table 116. Mylan Pharmaceuticals Product
Table 117. Mylan Pharmaceuticals Revenue in Amyotrophic Lateral Sclerosis Business (2015-2020) (Million US$)
Table 118. Mylan Pharmaceuticals Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amyotrophic Lateral Sclerosis Market Share by Type: 2020 VS 2026
Figure 2. Stem Cell Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Global Amyotrophic Lateral Sclerosis Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Diagnostic Centres Case Studies
Figure 7. Clinics Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Amyotrophic Lateral Sclerosis Report Years Considered
Figure 10. Global Amyotrophic Lateral Sclerosis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Amyotrophic Lateral Sclerosis Market Share by Regions: 2020 VS 2026
Figure 12. Global Amyotrophic Lateral Sclerosis Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Amyotrophic Lateral Sclerosis Market Share by Players in 2019
Figure 15. Global Top Amyotrophic Lateral Sclerosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Revenue in 2019
Figure 17. North America Amyotrophic Lateral Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Amyotrophic Lateral Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Amyotrophic Lateral Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Amyotrophic Lateral Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Amyotrophic Lateral Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Amyotrophic Lateral Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Amyotrophic Lateral Sclerosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. GNT Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. GNT Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Business (2015-2020)
Figure 26. Synthetic Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Synthetic Biologics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Business (2015-2020)
Figure 28. Avicena Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Avicena Revenue Growth Rate in Amyotrophic Lateral Sclerosis Business (2015-2020)
Figure 30. Amkor Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Amkor Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Business (2015-2020)
Figure 32. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Business (2015-2020)
Figure 34. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Business (2015-2020)
Figure 36. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Biogen Revenue Growth Rate in Amyotrophic Lateral Sclerosis Business (2015-2020)
Figure 38. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis Business (2015-2020)
Figure 40. Mylan Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Mylan Pharmaceuticals Revenue Growth Rate in Amyotrophic Lateral Sclerosis Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed